Hemodialysis-Related Low Thrombogenicity Measured by Total Thrombus-formation Analysis System in Patients Undergoing Percutaneous Coronary Intervention

Established antithrombotic therapies can increase bleeding risk, especially in hemodialysis (HD) patients. The Total Thrombus-formation Analysis System (T-TAS) is useful for evaluating thrombogenicity. The aim of this study was to examine the relationship between HD and thrombogenicity, or bleeding events in patients undergoing percutaneous coronary intervention (PCI).

Source: Thrombosis Research - February 6, 2021 Category: Hematology Authors: Nobuhiro Nakanishi, Koichi Kaikita, Masanobu Ishii, Naoto Kuyama, Noriaki Tabata, Miwa Ito, Kenshi Yamanaga, Koichiro Fujisue, Tadashi Hoshiyama, Hisanori Kanazawa, Shinsuke Hanatani, Daisuke Sueta, Seiji Takashio, Yuichiro Arima, Satoshi Araki, Hiroki Us Tags: Original Investigation Source Type: research